-
公开(公告)号：US11883179B2
公开(公告)日：2024-01-30
申请号：US17001424
申请日：2020-08-24
Applicant: Medtronic, Inc.
Inventor： Robert W. Stadler , Xusheng Zhang , Vinod Sharma , James D. Reinke , Barbara J. Schmid
CPC classification number: A61B5/363 , A61B5/346 , A61B5/686 , A61N1/3621 , A61N1/3756 , A61N1/37264 , A61N1/37288 , A61N1/3962 , A61N1/3987 , A61N1/39622
Abstract: An implantable medical device comprises a sensing module configured to obtain electrical signals from one or more electrodes and a control module configured to process the electrical signals from the sensing module in accordance with a tachyarrhythmia detection algorithm to monitor for a tachyarrhythmia. The control module detects initiation of a pacing train delivered by a second implantable medical device, determines a type of the detected pacing train, and modifies the tachyarrhythmia detection algorithm based on the type of the detected pacing train.
-
公开(公告)号：US11724111B2
公开(公告)日：2023-08-15
申请号：US17234746
申请日：2021-04-19
Applicant: MEDTRONIC, INC.
Inventor： Hyun J. Yoon , Wade M. Demmer , Matthew J. Hoffman , Robert A. Betzold , Jonathan D. Edmonson , Michael L. Ellingson , Ben W. Herberg , Juliana E. Pronovici , James D. Reinke , Todd J. Sheldon , Paul R. Solheim
CPC classification number: A61N1/3718 , A61N1/3931 , A61N1/3684 , A61N1/3688 , A61N1/3956
Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.
-
公开(公告)号：US11660455B2
公开(公告)日：2023-05-30
申请号：US17355905
申请日：2021-06-23
Applicant: Medtronic, Inc.
Inventor： David J. Peichel , Jonathan P. Roberts , James D. Reinke , Michael B. Terry
CPC classification number: A61N1/37217 , A61N1/3756 , A61N1/37288 , A61N1/3956 , A61N1/05 , A61N1/37264 , A61N1/3975
Abstract: A device, such as an IMD, having a tissue conductance communication (TCC) transmitter controls a drive signal circuit and a polarity switching circuit by a controller of the TCC transmitter to generate an alternating current (AC) ramp on signal having a peak amplitude that is stepped up from a starting peak-to-peak amplitude to an ending peak-to-peak amplitude according to a step increment and step up interval. The TCC transmitter is further controlled to transmit the AC ramp on signal from the drive signal circuit and the polarity switching circuit via a coupling capacitor coupled to a transmitting electrode vector coupleable to the IMD. After the AC ramp on signal, the TCC transmitter transmits at least one TCC signal to a receiving device.
-
34.发明授权公开(公告)号：US10828494B2
公开(公告)日：2020-11-10
申请号：US15813189
申请日：2017-11-15
Applicant: Medtronic, Inc.
Inventor： Scott A. Hareland , James K. Carney , James D. Reinke , Jon D. Schell , Barbara J. Schmid
Abstract: An implantable medical device comprising a signal generator configured to generate and deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient and processing circuitry. The processing circuitry is configured to detect an enable event, responsive to detecting the enable event, enable the delivery of ATP by the signal generator, detect a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, and responsive to detecting the disable event, disable delivery of ATP.
-
公开(公告)号：US10773088B2
公开(公告)日：2020-09-15
申请号：US15484430
申请日：2017-04-11
Applicant: Medtronic, Inc.
Inventor： James K. Carney , Saul E. Greenhut , Jonathan L. Kuhn , James D. Reinke , David J. Peichel , James W. Busacker
IPC: A61N1/372 , A61N1/365 , A61N1/39 , A61B5/00 , H04B13/00 , A61N1/368 , A61N1/375 , A61B5/042 , A61N1/362
Abstract: Systems, devices, and techniques for establishing communication between two medical devices are described. In one example, an implantable medical device comprises communication circuitry, therapy delivery circuitry, and processing circuitry configured to initiate a communication window during which the implantable second medical device is capable of receiving the information related to a cardiac event detected by a first medical device, the communication window being one of a plurality of communication windows defined by a communication schedule that corresponds to a transmission schedule in which the first medical device is configured to transmit the information, control the communication circuitry to receive, from the first medical device, the information related to the cardiac event that is indicative of a timing of the cardiac event with respect to a timing of the communication window, schedule and control delivery of a therapy according to the information related to the cardiac event.
-
Patent Agency Ranking
公开(公告)号：US10197629B2
公开(公告)日：2019-02-05
申请号：US14244913
申请日：2014-04-04
Applicant: Medtronic, Inc.
Inventor： Charles R. Gordon , James D. Reinke , Val D. Eisele
Abstract: A method of generating at least one recommended replacement time signal for a battery is provided. The method includes measuring a plurality of associated unloaded and loaded battery voltages. A delta voltage for each associated unloaded and loaded battery voltage is then determined. A select number of delta voltages are averaged. A minimum delta voltage is determined from a plurality of the averaged delta voltages. At least one recommended replacement time signal for the battery is generated with the use of the minimum delta voltage when at least one averaged delta voltage is detected that has at least reached a replacement threshold.
-
37.发明授权公开(公告)号：US09844675B2
公开(公告)日：2017-12-19
申请号：US15143038
申请日：2016-04-29
Applicant: Medtronic, Inc.
Inventor： Scott A. Hareland , James K. Carney , James D. Reinke , Jon D. Schell , Barbara J. Schmid
CPC classification number: A61N1/3621 , A61N1/37205 , A61N1/37252 , A61N1/37288 , A61N1/3756 , A61N1/39 , A61N1/3962 , A61N1/39622 , A61N1/3987
Abstract: An implantable medical device comprising a signal generator configured to generate and deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient and processing circuitry. The processing circuitry is configured to detect an enable event, responsive to detecting the enable event, enable the delivery of ATP by the signal generator, detect a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, and responsive to detecting the disable event, disable delivery of ATP.
-
38.发明申请公开(公告)号：US20170312514A1
公开(公告)日：2017-11-02
申请号：US15143038
申请日：2016-04-29
Applicant: Medtronic, Inc.
Inventor： Scott A. Hareland , James K. Carney , James D. Reinke , Jon D. Schell , Barbara J. Schmid
CPC classification number: A61N1/3621 , A61N1/37205 , A61N1/37252 , A61N1/37288 , A61N1/3756 , A61N1/39 , A61N1/3962 , A61N1/39622 , A61N1/3987
Abstract: An implantable medical device comprising a signal generator configured to generate and deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient and processing circuitry. The processing circuitry is configured to detect an enable event, responsive to detecting the enable event, enable the delivery of ATP by the signal generator, detect a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, and responsive to detecting the disable event, disable delivery of ATP.
-
公开(公告)号：US20170232261A1
公开(公告)日：2017-08-17
申请号：US15141430
申请日：2016-04-28
Applicant: Medtronic, Inc.
Inventor： Robert W. Stadler , Zhongping Yang , Sarah A. Audet , James K. Carney , James D. Reinke , Andrew J. Ries , John D. Wahlstrand
CPC classification number: A61N1/36585 , A61B5/0422 , A61N1/057 , A61N1/36542 , A61N1/37288 , A61N1/3756 , A61N1/3787
Abstract: An implantable medical device system is configured to deliver cardiac pacing by receiving a cardiac electrical signal by sensing circuitry of a first device via a plurality of sensing electrodes, identifying by a control module of the first device a first cardiac event from the cardiac electrical signal, setting a first pacing interval in response to identifying the first cardiac event, controlling a power transmitter of the first device to transmit power upon expiration of the first pacing interval, receiving the transmitted power by a power receiver of a second device; and delivering at least a portion of the received power to a patient's heart via a first pacing electrode pair of the second device coupled to the power receiver.
-
公开(公告)号：US09643024B2
公开(公告)日：2017-05-09
申请号：US15060667
申请日：2016-03-04
Applicant: Medtronic, Inc.
Inventor： James D. Reinke , Glenn M. Roline , Shohan T. Hossain , Michael W. Heinks
CPC classification number: A61N1/3962 , A61N1/3621 , A61N1/3624 , A61N1/37 , A61N1/3756 , A61N1/3937
Abstract: An implantable pacemaker detects delivery of an anti-tachyarrhythmia shock by another device. The implantable pacemaker delivers cardiac stimulation therapy within a patient. The implantable pacemaker senses, via the electrode pair, an electrical signal. The implantable pacemaker detects the anti-tachyarrhythmia shock based on the sensed electrical signal by detecting DC voltage polarization across the electrode pair within the patient. The implantable pacemaker alters the cardiac stimulation therapy based on the detected anti-tachyarrhythmia shock.
-
-
-
-
-
-
-
-
-
Search Results
82
records
(took 0.026 seconds)
